Cargando…
FOXP1 suppresses immune response signatures and MHC class II expression in activated B-cell-like diffuse large B-cell lymphomas
The FOXP1 (forkhead box P1) transcription factor is a marker of poor prognosis in diffuse large B-cell lymphoma (DLBCL). Here microarray analysis of FOXP1-silenced DLBCL cell lines identified differential regulation of immune response signatures and major histocompatibility complex class II (MHC II)...
Autores principales: | Brown, P J, Wong, K K, Felce, S L, Lyne, L, Spearman, H, Soilleux, E J, Pedersen, L M, Møller, M B, Green, T M, Gascoyne, D M, Banham, A H |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4777777/ https://www.ncbi.nlm.nih.gov/pubmed/26500140 http://dx.doi.org/10.1038/leu.2015.299 |
Ejemplares similares
-
FOXP2-positive diffuse large B-cell lymphomas exhibit a poor response to R-CHOP therapy and distinct biological signatures
por: Wong, Kah Keng, et al.
Publicado: (2016) -
Vitamin D Receptor Expression in Plasmablastic Lymphoma and Myeloma Cells Confers Susceptibility to Vitamin D
por: Gascoyne, Duncan M., et al.
Publicado: (2016) -
The Forkhead Transcription Factor FOXP2 Is Required for Regulation of p21(WAF1/CIP1) in 143B Osteosarcoma Cell Growth Arrest
por: Gascoyne, Duncan M., et al.
Publicado: (2015) -
CRISPR/Cas9-Mediated Foxp1 Silencing Restores Immune Surveillance in an Immunocompetent A20 Lymphoma Model
por: Felce, Suet Ling, et al.
Publicado: (2020) -
Early BCR Events and Antigen Capture, Processing, and Loading on MHC Class II on B Cells
por: Avalos, Ana M., et al.
Publicado: (2014)